KarlGCsakyMD

Ophthalmology • Dallas, TX

Physician

Join to view full profile

Dr. Csaky is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Csaky's full profile

Already have an account?

Office
9600 N Central Expressway
Suite 100
Dallas, TX 75231
Phone+1 214-692-6941

Education & Training

Washington University/B-JH/SLCH ConsortiumResidency, Ophthalmology, 1987 - 1990
Duke University HospitalInternship, Internal Medicine, 1983 - 1984
University of Louisville School of MedicineClass of 1983

Certifications & Licensure

TX State Medical License 2009 - 2026
NC State Medical License 2007 - 2013
DC State Medical License 1991 - 2010
MD State Medical License 1990 - 1992
American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2013
Fellow (FAAO) American Academy of Ophthalmology

Clinical Trials

TAC-PF, Avastin® in Combination With Photodynamic Therapy to Treat Age Related Macular Degeneration Start of enrollment: 2007 Jan 01
Terminated
Phase 2
Effect of Ozurdex® 0.7 mg on Improvement of Efficacy of Bevacizumab for Central Retinal Vein Occlusion Start of enrollment: 2011 May 01
Completed
Phase 2, Phase 3
A Randomized, Multi-center, Phase II Study of the Safety, Tolerability and Bioactivity of Repeated Intravitreal Injections of iCo-007 as Monotherapy or in Combination With Ranibizumab or Laser Photocoagulation in the Treatment of Diabetic Macular Edema (the iDEAL Study) Start of enrollment: 2012 Feb 01
Terminated
Phase 2
Safety and Efficacy of rAAV-hRS1 in Patients With X-linked Retinoschisis (XLRS) Start of enrollment: 2015 May 01
Completed
Phase 1, Phase 2
Join now to see all

Publications & Presentations

PubMed

Photoreceptor assessment in age-related macular degeneration.
Amitha Domalpally, Anna-Maria Haas, Shruti Chandra, Brandon VanderZee, Ioannis S Dimopoulos
Eye. 2025-02-01
Phase 1 Study of JNJ-81201887 Gene Therapy in Geographic Atrophy Secondary to Age-Related Macular Degeneration.
Jeffrey S Heier, Michael N Cohen, Daniel L Chao, Anthony Pepio, Yoko Shiraga
Ophthalmology. 2024-12-01
Visual Loss in Geographic Atrophy: Learnings from the Lampalizumab Trials.
Neha Anegondi, Verena Steffen, Srinivas R Sadda, Steffen Schmitz-Valckenberg, Adnan Tufail
Ophthalmology. 2024-11-23

Journal Articles

Effect of Oral Valproic Acid vs Placebo for Vision Loss in Patients with Autosomal Dominant Retinitis Pigmentosa
David G Birch, Michael P Teske, Richard G Weleber, Robert Lindblad, Byron L Lam, Judith Warner, Gary Edd Fish, Neal L Sklaver, Mark E Pennesi, John Heckenlively, Paul ..., JAMA

Press Mentions

Week in Review: AMD Video Game, RNFL Thinning Linked to Diabetes and Hypertension, Safer IOP MeasurementFebruary 14th, 2022
October 14, 2019October 14th, 2019
Can Dry Macular Degeneration Be Diagnosed Through Video Games?July 15th, 2019

Grant Support

Development Of Therapies For Age-Related Macular DegenerNational Eye Institute2006
Study Of Cellular Death In Retinal Pigment Epithelial CENational Eye Institute2003–2006
Study Of An Animal Model Of Choroidal NeovascularizationNational Eye Institute2003–2006
Gene Expression In Cells From Patients With Age-RelatedNational Eye Institute2002–2006
Therapies For Age-Related Macular DegenerationNational Eye Institute2005
Study Of Cellular Death In RPE CellsNational Eye Institute2005
Feeder Vessels In Patients With Neovascular AMDNational Eye Institute2005
Gene Expression In Cells From Patients With AMDNational Eye Institute2004–2005
Multi-Center, Randomized, Prospective Clinical TrialNational Eye Institute2004
Feeder Vessels In Neovascular Macular DegenerationNational Eye Institute2003–2004
Prospective Clinical Trial To Celebrex With PDT In AMDNational Eye Institute2003
Gene Expression In Age-Related Macular DegenerationNational Eye Institute2003
Feeder Vessels In Patients With Neovascular Macular DegeNational Eye Institute2002
Study Of Cellular Injury In Retinal Pigment Epithelial CNational Eye Institute2001–2002
Development Of An Animal Model Of Choroidal NeovasculariNational Eye Institute2001–2002
Vessels In Patient With Neovascular Macular DegenerationNational Eye Institute2001
Gene Expression In Macular DegenerationNational Eye Institute2001
Fluocinolone Acetonide In Choroidal NeovascularizationNational Eye Institute2000
Development Of Animal Model Of Choroidal NeovascularizatNational Eye Institute2000
Cellular Injury In Retinal Pigment Epithelial CellsNational Eye Institute2000
Ocular Gene TransferNational Eye Institute1999–2000